Apollo ESG NXT System, Apollo REVISE NXT System

FDA 510(k) K232544 · Apollo Endosurgery, Inc.

Substantially Equivalent

510(k) numberK232544

Submission

Device name
Apollo ESG NXT System, Apollo REVISE NXT System
Applicant
Apollo Endosurgery, Inc.
Austin, TX, US
Received
August 22, 2023
Decision date
September 18, 2023
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QTD – Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss
Device class
Class II (moderate risk)
Regulation
21 CFR 876.5983
Specialty
Gastroenterology, Urology
Implant
Yes

This endoscopic device uses suturing to approximate gastric tissue to restrict the volume of the stomach for the intended purpose of weight loss.

More from Apollo Endosurgery, Inc.

510(k)DeviceDecision
K231553OverStitch NXT Endoscopic Suturing SystemOCW · Special 06/29/2023SE
K210266OverStitch Sx Endoscopic Suturing SystemOCW · Special 03/02/2021SE
K201808X-Tack Endoscopic HeliX Tacking SystemPKL · Traditional 12/15/2020SE
K191439OverStitch 2-0 Polypropylene SutureOCW · Traditional 08/29/2019SE
K181141OverStitch Endoscopic Suturing System and AccessoriesOCW · Special 06/27/2018SE
K171886OverStitch SX Endoscopic Suturing System (ESS)OCW · Traditional 11/15/2017SE
K122270Overtube Endoscopic Access SystemFED · Traditional 09/28/2012SE
K103155Sumo Access and Tissue Resection SystemODC · Traditional 10/28/2011SE
K082102Gastric Port, Models: GAP-0016-00, GAP-0018-00, GAP-0020-00FED · Traditional 06/14/2010SESU
K090583Endoscopic Monopolar Scissors, Models EMS-235, EMS-165KGE · Traditional 06/26/2009SE

Questions and answers

When was Apollo ESG NXT System, Apollo REVISE NXT System cleared by the FDA?

Apollo ESG NXT System, Apollo REVISE NXT System (K232544) received a 510(k) decision of Substantially Equivalent on September 18, 2023, 27 days after the submission was received.

What is the product code of K232544?

The FDA product code is QTD – Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss, a Class II (moderate risk) device regulated under 21 CFR 876.5983.